PAVE syndrome could be fatal

Article

Presumed Air by Vitrectomy Embolisation (PAVE) could be a fatal syndrome, states a paper in the British Journal of Ophthalmology.

Presumed Air by Vitrectomy Embolisation (PAVE) could be a fatal syndrome, states a paper in the British Journal of Ophthalmology.

A study led by Dr Robert E. Morris, Helen Keller Foundation for Research and Education, Birmingham, Alabama, USA, included the analysis of three cases of suspected venous air embolism (VAE). The team investigated how air exits the eye through vortex veins after accidental suprachoroidal air infusion.

The group performed vitrectomy on four donor eyes. During air fluid exchange the unsutured cannulas were partially withdrawn and this produced choroidal detachments that imitated accidental suprachoroidal air infusion from a slipping cannula. A water bath was used to partially submerge eyes with and without clamping of the vortex vein stumps.

According to the findings, extensive choroidal detachment was created in all eyes and all patients with open vortex veins demonstrated rapid air extravasation/bubbling.

The results of the experiment support the recognition of PAVE and demonstrate that simple surgical precautions can prevent the potentially fatal vitrectomy complication.

Please click here to read the abstract.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.